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Abstract
Background: With the advent of next generation sequencing it has become possible to detect genomic variation
on a large scale. However, predicting which genomic variants are damaging to gene function remains a challenge,
as knowledge of the effects of genomic variation on gene expression is still limited. Recombinant inbred panels
are powerful tools to study the cis and trans effects of genetic variation on molecular phenotypes such as gene
expression.
Results: We generated a comprehensive inventory of genomic differences between the two founder strains of the
rat HXB/BXH recombinant inbred panel: SHR/OlaIpcv and BN-Lx/Cub. We identified 3.2 million single nucleotide
variants, 425,924 small insertions and deletions, 907 copy number changes and 1,094 large structural genetic
variants. RNA-sequencing analyses on liver tissue of the two strains identified 532 differentially expressed genes
and 40 alterations in transcript structure. We identified both coding and non-coding variants that correlate with
differential expression and alternative splicing. Furthermore, structural variants, in particular gene duplications, show
a strong correlation with transcriptome alterations.
Conclusions: We show that the panel is a good model for assessing the genetic basis of phenotypic
heterogeneity and for providing insights into possible underlying molecular mechanisms. Our results reveal a high
diversity and complexity underlying quantitative and qualitative transcriptional differences.
Background
Thanks to technological developments in next genera-
tion DNA sequencing the amounts of genetic variants
that are identified in healthy and diseased individuals
are growing rapidly. This has increased the potential of
personal genomics: the sequencing of complete genomes
with the intention to guide prevention or treatment stra-
tegies. For personal genomics to become a reality, how-
ever, it is important not only to systematically make
inventories of genome-wide genetic variation, but also
to know which genetic alterations can affect gene func-
tion [1,2]. Studying the effects of genomic variation in
human populations is difficult, due to the large number
of variants in every individual. Moreover, alleles can be
heterozygous and homozygous with both recessive and
dominant effects.
Here we have systematically studied the effects of
genomic variants using two inbred rat strains, the
spontaneously hypertensive rat (SHR/OlaIpcv) and a
Brown Norway-derived strain, BN-Lx/Cub [3,4]. We
refer to the strains as SHR and BN-Lx in this paper.
The advantage of using inbred animals for genetic stu-
dies is that essentially all positions in the genome are
homozygous. In addition, the strains form a renewable
biological source, which makes it possible to analyze
biological replicates and to do extensive validation stu-
dies. The SHR and BN-Lx strains are a particularly
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valuable system for studying the phenotypic effects of
genetic variation, because they are the founders of a
recombinant inbred (RI) panel, which is called HXB/
BXH.
RI panels are created by crossing two inbred lines.
Through inbreeding of the offspring new inbred lines
are established that are mosaics of the two founder
strains. The HXB/BXH RI panel consists of 30 lines that
have been inbred for currently >80 generations. Exten-
sive phenotyping has been performed at the physiologi-
cal, behavioral and molecular levels (reviewed in [5]).
Genetic maps were generated and quantitative trait loci
(QTLs) have been identified through linkage analyses in
the panel (reviewed in [5]). By analyzing gene expression
levels in the RI panel, thousands of local (cis) and
remote (trans) genetic loci that affect transcription,
called expression QTLs or eQTLs, have been identified
[6] and transcriptional networks have been dissected [7].
Due to the high level of synteny between rat and
human, results obtained in the rat have been success-
fully extrapolated to human (reviewed in [8]). For exam-
ple, a QTL study in a rat RI panel has recently led to
the identification of the ENDOG gene as an important
regulator of cardiac hypertrophy. The homologous gene
in human was shown to be involved in the same biologi-
cal processes as the rat gene [9].
To use the HXB/BXH RI panel for functional genetic
analyses, a comprehensive inventory of the genomic dif-
ferences between the founder strains is required. More-
over, such a resource will be essential to identify causal
genes and variants that underlie physiological pheno-
types in QTL regions. The genome of SHR was
sequenced previously to 10× coverage [10]. This was
shown to be instrumental for the identification of tran-
scriptional regulators [7].
Here we re-sequenced the genome of BN-Lx. In addi-
tion, we updated the sequence of SHR by increasing the
sequencing depth and employing novel analysis methods
[10]. An extensive spectrum of genomic variants was
characterized; single nucleotide variants (SNVs), inser-
tions and deletions smaller that 10 bp (indels), copy
number variants (CNVs) and structural genetic variants
(SVs). SVs include deletions insertions tandem duplica-
tions and inversions.
We also performed RNA sequencing on liver samples
of SHR and BN-Lx and identified both qualitative and
quantitative differences in the transcriptomes. Analyses
on the effects of the different genomic variants show
that SVs, and in particular gene duplications, strongly
correlate with quantitative transcriptomic output.
Furthermore, combining genetic variation inventories
with RNA-seq analyses provides clues on the mechan-
ism of qualitative transcriptional alterations.
Results
Genome sequencing data
A summary of the next generation sequencing (NGS)
data produced in this study is shown in Additional file
1. We previously sequenced the SHR genome with med-
ian coverage of 10× [10]. By expanding the NGS data
set of SHR the median coverage of this genome was
increased to 23× (Figure 1a). For the analyses of the
BN-Lx genome we produced three independent frag-
ment libraries and a long mate-pair library. Combined
this resulted in 33× median base coverage of this gen-
ome (Figure 1a). The BN/NHsdMcwi strain has been
used to create the reference genome of the rat [11]. We
refer to this strain as the reference BN. This strain was
sequenced by traditional capillary sequencing and has
not been covered to the same depth as we generated
here for BN-Lx and SHR. Lack of coverage in the refer-
ence may contribute to false discovery of genomic var-
iants in BN-Lx and SHR. To prevent false discoveries,
we used novel whole genome NGS data that were gen-
erated from material from the same animal (named Eve)
that was used to create the BN reference sequence. We
used these data from the BN reference with 32× NGS
coverage to filter for likely reference genome errors.
Small genomic variants
We used two variant calling algorithms for SNV detec-
tion, which were employed on the SHR, BN-Lx and BN
reference data. For each SNV position found in either
BN-Lx or SHR we checked that the SNV was not found
in the reference BN sample. We took the SNVs found
by both callers to come to the final SNV set reported
here (Additional file 2 contains a list of all SNVs in
SHR; Additional file 3 contains a list of all SNVs identi-
fied in BN-Lx). The results of both SNV callers can be
viewed in separate tracks in the Rat Genome Database
[12].
We detected 15,627 homozygous SNVs unique to BN-
Lx and 3,162,031 unique to SHR (Figure 1b) as com-
pared, respectively, to the BN reference, adding up to a
total of 3,177,658 SNVs within the RI panel. Capillary
sequencing confirmed 70 of the 70 randomly selected
homozygous SNVs (100%; Additional file 4). Although
inbred strains are expected to be homozygous at each
position, we also found 17,544 heterozygous positions
specific for SHR and 225 specific for BN-Lx. Possible
sources of heterozygous SNVs include recent de novo
mutations, sequencing noise, incomplete inbreeding and
diverged duplications. The latter two mechanisms are
expected to result in clustering of heterozygous posi-
tions, whereas noise and de novo mutations would
appear randomly. We analyzed the genome of SHR in
100 kb windows and found that the distribution of
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heterozygous SNVs is far from random; 84% of the het-
erozygous SNVs locate to windows with more than
three SNVS. Of simulated randomly positioned SNVs,
only 2.6% are located in such SNV-dense windows.
Furthermore, 91 of the 148 genomic regions with the
highest density of heterozygous SNVs (top 1%) were
found to overlap with duplications, indicating that
diverged duplications are a major source of heterozy-
gous SNVs.
The homozygous SNVs between BN-Lx and the BN
reference genome are also not distributed randomly
across the genome. There are eight regions with a high
SNV density, with a combined length of 51 Mb,
together holding 97% of the SNVs (Figure S1A in
Additional file 5). One of these regions, on chromo-
some 8, was expected to have a high density of SNVs
because BN-Lx is known to be congenic for this
region, which contains the Lx locus [4]. The discovery
of the other seven regions demonstrates that there are
more sub-chromosomal differences between BN-Lx
and the reference than was expected based on the
breeding history. These differential regions could be
remnants of the original cross with the PD strain that
created the congenic strain that was the founder for
BN-Lx. To investigate this possibility, we analyzed a
subset of the SNVs in other rat strains. Saar et al. [13]
previously characterized 127 SNV positions in the 7
regions that differ between BN-Lx and the reference
genome by high-throughput genotyping in 167 strains
and substrains. Nine BN substrains from different
institutes were included in this study. We found that a
subset of the BN substrains has the same genotype in
the seven polymorphic regions as BN-Lx (Figure S1B
in Additional file 5). This shows that variants likely
reflect the background of the BN strain that was used
as a founder for generating the BN-Lx strain rather
than remnants of the PD strain.
We did not find genomic regions with increased SNV
density in SHR. We detected 220,332 additional SNVs
that were not found in the analyses based on the 10×
coverage of the SHR genome [10]. We also found
76,019 positions that were previously called homozygous
SNV to be also non-reference in BN (6,077 positions),
BN-Lx (28,751 positions) or both (41,191 positions),
indicating that these most likely reflect errors in the
reference genome assembly.
Figure 1 Full genome sequencing identifies broad spectrum of genetic variants. (a) Coverage profiles of SHR and BN-Lx. (b) The amount
of different types of genomic variants detected in BN-Lx and SHR. (c) The distribution of sizes of indels that were detected. Nd, not determined.
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Next, we used the overlap between the two indepen-
dent analysis tools to reliably call indels in the two rat
strains. We identified 1,615 indels specific for BN-Lx
and 424,309 specific for SHR (Figure 1b; Additional files
6 and 7 for SHR and BN-Lx, respectively). We analyzed
57 indels with capillary sequencing and confirmed all 57
(100%; Additional file 8). We called indels ranging from
one to ten base pairs; 36% of the indels are larger than
1 bp (Figure 1c) and a large proportion (51%) of the
indels are changes in the length of homopolymer
stretches longer than 3 bp (82% of these involve A or T
stretches).
Fifty percent of the SHR indels were not found in the
previous analysis, and 27,416 of the 343,243 indels
detected in the previous analyses were found to be not
specific to SHR, of which 19,138 were found in both
BN-Lx and the reference strain. These differences are
not only the result of a higher base coverage, but are
also due to a change in analysis methods. The previous
report was based on a combination of MAQ and BLAT
alignments [10] and here we used two independent
indel calling algorithms. Moreover, the previous set was
not corrected for reference errors.
As was seen for the SNVs, the indels that are seen in
BN-Lx compared to the BN reference are found clus-
tered in the genome; 93% of the BN-Lx indels are found
in the eight regions that are different between BN-Lx
and the reference.
Structural variation
We detected SVs by two independent methods: based
on raw read coverage and by long mate-pair (LMP)
analyses.
NGS coverage differences between either SHR or BN-
Lx and the reference BN can be used to detect changes
in copy number. Using a dynamic window binning
approach to identify genomic segments with differential
NGS read coverage (DWAC-Seq; VG, manuscript in
preparation), we identified four duplications in BN-Lx
and four deletions compared to the BN reference,
including a known 3 kb deletion on chromosome 8 [14].
In SHR we identified 384 duplications and 461 deletions
(Figure 1b). The duplications ranged from 1,028 bp to
270 kb covering 7.3 Mb in total, and the deletions ran-
ged from 1,036 bp to 2.3 Mb covering 11.7 Mb in total.
Some SVs are not detectable based on sequence cov-
erage due to the repetitive nature of the sequence con-
tent or because they are copy neutral. Therefore, we
analyzed LMP data for SHR and BN-Lx. In brief, LMP
analysis involves DNA fragmentation, selection of frag-
ments of a specific size range and sequencing of the
ends of these selected fragments. The sequenced ends
are aligned to the reference sequence and are expected
to align at a distance from each other that matches the
selected fragment size range. Mate-pairs that map at a
different distance or in an unexpected orientation pin-
point changes in genome structure, which can be dele-
tions, tandem duplications, insertions, inversions or
translocations [15]. The SHR LMP library had a median
insert size of 2 kb [10] and as a control we produced a
LMP library of the reference BN with the same insert
size. We found 76 tandem duplications, 97 inversions
and 900 deletions specific for SHR. The mate-pair
library of BN-Lx has a median insert size of 5.5 kb. In
BN-Lx we identified 4 deletions and the large insert size
of the BN-Lx mate-pair library allowed the identification
of 17 insertions (Figure 1b).
The analyses on NGS coverage and LMP libraries
combined results in a comprehensive list of SVs in SHR
and BN-Lx versus the reference BN (Additional file 9).
Transcriptome variations in liver
To investigate the effects of the genomic variation on
transcriptome characteristics, we performed RNA
sequencing on liver samples of SHR and BN-Lx1. We
sequenced the mRNA of three animals of each strain to
control for inter-animal diversity. By polyA and 5’-cap
selection we obtained the full length mRNA products
from the pool of total RNA. Strand information was
preserved in the library preparation procedure. We
obtained over 7.4 million mapped reads for each animal
and 78 to 80% of the reads mapped to coding sequences
(Figure 2a).
Using normalized read counts per gene as a measure
for gene expression and taking intra-strain variation into
account, we identified 532 differentially expressed genes
with a minimum of a two-fold difference between BN-
Lx and SHR (false discovery rate (FDR) <5%). We ran-
domly selected 12 differentially expressed genes that dif-
fered between 2 and 21 fold and analyzed them by
quantitative PCR (qPCR). Expression of all 12 genes was
confirmed to be significantly different between SHR and
BN-Lx in the qPCR experiments (P-values 9.8 × 10E-09
to 0.04, one sided two sample t-test, assuming equal
variance) and the fold changes showed a median 1.6-
fold difference between the two methods (Figure 2b).
The qPCR experiments thus confirm our RNA-seq
analyses.
We also investigated the differences in splicing events
between the two rat strains (Figure 2c). For this purpose
we created a reference transcriptome consisting of all
combinations of annotated exons. We mapped the
RNA-seq data to this transcriptome reference and quan-
tified sequencing reads that mapped across exon-exon
junctions. Because the goal was to relate splicing differ-
ences to genetic variation, rather than to identify all
splicing variants in the transcriptome, we selected the
exon-exon junctions with the largest differences between
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Figure 2 The transcriptomes of SHR and BN-Lx liver have differences in both expression levels and splicing events. (a) The amount of
sequencing reads that could be mapped to the genome per RNA-seq library. Three animals were analyzed for each strain. (b) Twelve genes
found to be differentially expressed between BN-Lx and SHR with RNA-seq were analyzed with qPCR. (c) Schematic representation of alternative
splicing analyses. To analyze splicing events a novel reference was created by combining the sequences of the annotated exon ends. RNA-seq
reads were mapped to this reference and junctions used differentially by BN-Lx and SHR were determined.
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the strains. We found 38 junctions with large differences
in coverage between SHR and BN-Lx in 36 genes; 27 of
the junctions are annotated and 11 are new combina-
tions within a gene (Additional file 10).
Thus, there are both quantitative and qualitative dif-
ferences between the transcriptomes of BN-Lx and SHR
in liver tissue.
Genomic variation in coding parts of differentially
expressed genes
Next we combined genomic and RNA-seq data to gain
insight into potential direct effects of different types of
genetic variants on the transcriptional output.
Combining the genomic sequence data from SHR and
BN-Lx, we found 25,271 SNVs in coding positions,
8,830 non-synonymous coding, 129 in essential splice
sites, 99 SNVs that cause a stop codon gain and 8 SNVs
that cause a stop codon loss (Additional file 11 lists the
affected genes and if they were expressed and differen-
tially expressed in liver tissue).
There are 402 indels located in coding sequence,
including 26 in essential splice sites and 260 indels that
cause a frameshift (Additional file 12 lists the affected
genes and if they were expressed and differentially
expressed in liver tissue). Another 1,394 and 119 indels
are located in 3’ and 5’ UTRs, respectively. Together, 1%
of the SNVs and indels are located in coding regions or
splice sites, and 489 genes are affected by essential splice
site, stop or frameshift variants.
Of the SVs (which include CNVs and structural var-
iants called in the LMP analyses), 6% contain at least
parts of coding sequences, together affecting 108 genes
(Additional file 13 lists the affected genes and if they
were expressed and differentially expressed in liver
tissue).
We investigated which types of genomic variants are
most likely to alter gene expression - in other words,
which have the highest predictive values. We focused
on the expressed genes for each variant and deter-
mined the fraction of genes that showed differential
expression levels between BN-Lx and SHR (Figure 3).
Deletions and duplications are often called by both
CNV and LMP analyses. We therefore combined these
sets to one list of genes affected by duplications and
Figure 3 Different types of genomic variants have different predictive value. For each type of genomic variant the genes that contained
such a variant were analyzed. The amount of expressed genes that overlapped each type of variant type is given in the right column. The
proportion of these genes that is differentially expressed between SHR and BN-Lx is represented by the red bars.
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one list of genes affected by deletions (relative contri-
bution of both analyses methods is given in Additional
file 13).
We found that full gene duplications have the highest
predictive value (Figure 3). The fraction of genes that is
differentially expressed is relatively low in the gene set
carrying SNVs. To gain insight into these differences,
we studied these effects of the different types of variants
in more detail.
Small genomic variants versus differential expression
levels
Novel stop codons can lead to degradation of the
mRNA through nonsense-mediated decay. Stop codons
can be introduced by SNVs and by frameshifts, which
can result from indels or splice site changes; 193 genes
carrying one of these types of variants are expressed in
liver, and only 19 of these are differentially expressed
between SHR and BN-Lx (Figure 3).
To verify that the lack of effect of stop mutations on
transcript levels is not due to false positive genomic var-
iants, we analyzed a subset with capillary sequencing.
We sequenced 17 SNVs that were predicted to create a
stop codon and were located in a gene that is expressed
in liver. All 17 positions were true SNVs (Additional file
14). This demonstrates that the lack of change in
expression is not due to false variant predictions.
An alternative hypothesis is that the functional predic-
tions are invalid. Visual inspection of the RNA-seq data
revealed that many of the stop variants in the unaffected
genes are located in exons that are not included in the
transcript in liver. Functional predictions can be
improved when data on alternative transcript usage
become more widely available. In addition, we found
many examples where inaccurate annotation results in
erroneous reading frame depictions and, as a result, in
false stop codon predictions. Thus, the limited effect of
predicted stop mutations on transcript levels is not due
to false variant detection, but rather the result of func-
tional predictions that are hampered by incomplete and
inaccurate gene annotation.
If functional predictions are improved, the total the
amount of SNVs and indels that are predicted to change
stop codons will likely decrease. The fraction of the stop
variants that has an effect on transcript level would then
be expected to become higher. However, what can be
estimated from the data presented here is that the total
contribution of stop variants to transcriptome variation
is low. Only 4% of the differentially expressed genes
contain a stop variant. These analyses do not capture
the full effects of novel stop codons. We have only
investigated liver here and it is possible that the effects
are larger in other tissues. Moreover, stop-codons could
also result in truncated proteins, without affecting
expression levels of the gene.
SVs in coding sequences of differentially expressed genes
Intuitively, a full gene deletion is the type of SV most
likely to change gene expression. However, gene dele-
tions cannot contribute to variation in the transcriptome
in liver tissue if the deleted genes are not active. Of the
13 genes that are predicted to be completely deleted,
only one, Uba2, is expressed in liver and this gene does
not show differential expression levels between BN-Lx
and SHR. This specific deletion in SHR was only
detected in the mate-pair analysis and was not found
based on genomic coverage. This suggests the gene
sequence is in the genome of SHR, but not at the same
position as in the reference genome. It is possible that
this gene translocated to a different part of the genome,
but is still functional. Unfortunately, there were no
mate-pairs with one end inside the deletion, so we
could not determine the translocation site based on the
LMP data. Alternatively, it is possible that the gene is
not translocated and is really deleted, but that the dele-
tion is missed in the coverage analyses.
Gene duplications are strongly correlated with changes
in expression. Five of the seven fully duplicated genes
that are expressed in liver are differentially expressed.
Three of the affected genes, RT1-T24-1, RT1-CE1 and
RT1-CE4, reside in a highly polymorphic region on
chromosome 20 coding for the MHC1 complex. This
part of the genome shows a complex pattern of varia-
tion at the genomic and transcriptomic levels. We inves-
tigated the data for the other two differentially expressed
genes found to be duplicated; Mx2 and Layn, in more
detail (Figure 4 shows the analyses for Layn; Figure S2
in Additional file 5 shows the analyses for Mx2). Visual
inspection of the coverage in the regions showed that
both duplications cover only the differentially expressed
gene and no other genes (Figure 4a; Figure S2A in Addi-
tional file 5). Both Mx2 and Layn show an increase in
expression (Figure 4b; Figure S2B in Additional file 5).
The elevated transcript levels could result from the fact
that there are four copies of the genes per cell instead
of two. Alternatively, the duplication of regulatory ele-
ments could result in up-regulation of the original two
gene copies. To investigate these hypotheses, we ana-
lyzed the heterozygous SNVs called in the genome in
the RNA-seq data. Both duplications contain heterozy-
gous SNVs. These can arise from diversification of the
sequence after duplication. Both the original and the
duplicated sequence map to the same position in the
reference genome and are detected as heterozygous
SNVs. We focused on the heterozygous SNVs in the
exons of the genes. All nine heterozygous genomic
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positions that are located in the Mx2 exons were also
heterozygous in the RNA-seq data (Figure S2C in Addi-
tional file 5). In Layn 6/8 heterozygous positions in the
exons showed expression from both alleles (Figure 4c).
In BN-Lx, which does not carry the duplications, all
described positions were homozygous reference at the
DNA and RNA levels. These data uniquely show that
the transcripts of Mx2 and Layn are produced from two
Figure 4 Duplication of the Layn gene locus in SHR results in transcription from the original and the extra allele. (a) Genomic coverage
(averaged over 999 bp) in SHR at the Mx2 locus. The site of the duplication is indicated with the white bar. (b) Expression levels as measured by
normalized RNA-seq read counts in the coding regions of the MX2 gene. The asterisk indicates significant difference (FDR <0.05). (c) Eight
heterozygous SNVs were found in the exons of Layn in the genomic sequencing data of SHR. RNA-seq reads covering these positions were
analyzed to investigate if they contained the reference or the alternative allele.
Simonis et al. Genome Biology 2012, 13:r31
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different alleles in SHR; the original locus and the extra
copy.
Some duplications and deletions cover only parts of
genes. There are 18 expressed genes with partial dupli-
cations, of which 5 are differentially expressed. Nineteen
genes with predicted partial deletions are expressed in
liver and five of these are differentially expressed. One
of the genes that is partially deleted is located in the
CD36 locus, which has a known functional deletion
[16]. The deletion in RT1-Bp causes the loss of the last
exon, described below. The other three partial deletions
found in differentially expressed genes were on visual
fine mapping and analyses of RNA-seq data all confined
to intronic sequences. Characterization of the deleted
sequences showed that they all contained >2,100 bp of a
repetitive element: two were remnants of long inter-
spersed elements (LINEs) and one was a long terminal
repeat (LTR) element (Figure 5). This led us to examine
other deletions in introns. Of the 100 deletions that
contain >2 kb of repetitive sequence, 21 are located in
introns. Nine of these genes are expressed in liver and
four are differentially expressed. These examples suggest
a possible effect on expression levels mediated by trans-
poson-derived sequences in introns.
The above described findings on duplications and
deletions demonstrate the potential of the HXB/BXH
model system for the elucidation of SV-mediated
changes in gene expression.
Figure 5 SVs covering intronic repetitive elements correlate with changes in gene expression. Three large intronic deletions (red bars) of
repetitive elements (grey bars) correlate with a change in gene expression (right). Asterisks indicate significant change (FDR <0.05). Exons
indicated in grey are not used in either strain, according to RNA-seq data.
Simonis et al. Genome Biology 2012, 13:r31
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Non-coding genomic variation and expression levels
An important part of the sequences that regulate gene
expression is located outside the coding parts of genes.
Therefore, we investigated the presence of genetic var-
iation in the 5’ and 3’ UTRs and in the 5 kb region
upstream of the transcriptional start sites. Of the
expressed genes in liver tissue, 2979 have at least one
SNV or indel in the 5’ and or 3’ UTR. Only 5% of
these genes are differentially expressed. Of the total set
of transcribed genes, 4% is differentially expressed.
Thus, the presence of an SNV at a conserved position
in a UTR does not make a gene much more likely to
be differentially expressed. So what about the number
of SNVs and indels in the regulatory regions? We
investigated SNV and indel density in the differentially
versus the non-differentially expressed gene set. We
found that the differentially expressed genes contain,
on average, 8.1 SNVs and 2.0 indels in the 5 kb
upstream of the transcriptional start site. The number
of small genomic variants is smaller in upstream
regions of genes that are not differentially expressed;
6.6 SNVs and 1.7 indels on average. Although the
absolute differences are small, they are highly signifi-
cant (two tailed t-test, P-value 0.0003 and 0.005 for
SNVs and indels, respectively). This is in accordance
with the previous finding that cis-eQTL gene loci are
enriched for SNVs and indels [10].
Differential splicing and splice site mutations
Next we analyzed the correlation between small geno-
mic variants and splicing. There are 129 SNVs and 26
indels located in essential splice sites. The quantitative
analyses of exon-exon junctions resulted in 36 genes
with differential splicing. Only one of these contained
a genomic variant, a SNV, directly in an essential
splice site (Figure 6a). This sequence change resulted
in the skipping of an exon in SHR (Figure 6b). The
affected gene, Slc22A18, is imprinted in mouse and
human and has been linked with tumorigenesis
[17,18]. The exon loss does not lead to a frame-shift
but results in a partial loss of a transmembrane
domain, which could be deleterious to the function of
the gene.
The lack of overlap between genomic variants and
splicing variation is not simply because the genes with
genomic variants in essential splice sites are not
expressed in the investigated tissue. Sixty-nine of the
genes with SNVs and 14 genes with indels in essential
splice sites are expressed, but only 8 junctions have
more than 2 reads mapped to them and none have
more than 7 mapped reads. This suggests that, at least
in liver, many transcripts are not spliced according to
the current annotation.
Alternative transcripts and genomic variants outside
splice sites
The finding that the genes that are differentially spliced
in BN-Lx and SHR do not contain genomic variants in
essential splice sites suggests that the alternative splicing
is caused by genomic variation at regulatory positions.
Splicing can be regulated by splicing factors that bind to
regulatory sites located in introns [19]. We therefore
investigated the genomic variants in the introns of the
affected sites. We selected the 27 splice junctions
formed between exons that neighbor each other in the
gene and, thus, cover only one intron. Of these 27
selected junctions, 17 had no genomic variant at all in
the intron. To detect possible functional sites in the ten
introns with genomic variants, we analyzed the phast-
Cons9way conservation scores per variant base. This
score represents the probability that a specific base is
conserved, with 1.0 indicating most likely conserved
[20]. All but one variant position had conservation
scores below 0.1. The highest conservation was 0.26, but
this SNV was not causative. In the intron with this SNV
there is another SNV 10 bp before the acceptor site,
which creates a new splice site and adds three amino
acids to the protein, which was confirmed by sequencing
the cDNA (Figure S3 in Additional data 5). The affected
gene is the highly conserved Fibrinogen alpha.
Despite this one example, the vast majority of quanti-
tative differences in splicing can not be linked with a
genomic variant in the corresponding intron.
While investigating differentially expressed genes we
found another source of alternative transcripts. Some of
the genes that overlap SVs not only change the expression
level of the annotated gene sequence, but also show novel
alternative transcripts. For example, the uncharacterized
gene D3ZCV5_RAT, which is duplicated in SHR, produces
a different transcript than the locus in BN-Lx (Figure 6c).
This gene shows differential expression, but was not
included in the total analyses presented in Figure 3a
because it is a novel gene without a Refseq ID. The RNA-
seq data for this gene do not show that different exons are
expressed in the duplicated locus in SHR (Figure 6c).
The highly polymorphic region of the MHC locus on
chromosome 20 shows a mixture of different SVs, dif-
ferences in expression levels and production of alterna-
tive transcripts (data not shown). There is one clear
example of a partial deletion that resulted in the loss of
an exon (Figure 6d), but more detailed functional ana-
lyses are necessary to elucidate the remainder of these
exceptionally complex sites.
Conclusions
We sequenced the SHR genome to high depth and pro-
duced a full genome analysis of BN-Lx to establish a
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Figure 6 Only a small part of the changes in transcript structures can be explained by underlying genomic variation. (a) The overlap
between splice junctions that are produced at different levels in SHR and BN-Lx and small genomic variants in essential splice sites. Only one of
the splice junctions that is different in BN-Lx and SHR carries a variant in an essential splice site. (b) The single differential splice junction that
overlaps with an SNV (arrow) results in exon skipping in Slc22A18C. The exons are indicated as black boxes. RNA-seq reads that mapped at this
gene locus are shown as small horizontal bars. The red scale indicates the amount of times each read was found in the data set. The number of
RNA-seq reads that mapped across the exon-exon junctions is represented in the numbers above the arcs. (c) Mapped RNA sequencing reads
(small black bars) in D3ZCV5_RAT show a different transcript structure in BN-Lx versus SHR. The different transcripts in the current annotation are
shown on top of the reads. The gene is duplicated in SHR (red bar) (d) A large deletion (red) in SHR covers the last exon of the RT1-Bp gene.
The deleted exon shows little coverage in the RNA-seq data of SHR.
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comprehensive resource of nucleotide and structural
genomic variants between these two founder strains of
the HXB/BXH RI panel. We identified 3.2 million SNVs
and 425,924 indels. Studies performed on three human
individuals detected 3.4 [21], 3.2 [22] and 3.3 [23] milion
SNVs and the numbers of indels detected in two of
these studies were 170,202 [21] and 292,102 [22]. Thus,
the number of SNVs and indels between the two inves-
tigated rat strains is highly comparable to the amounts
found when human individuals are compared to the
human reference genome [21-23].
In the model system used here the far majority of var-
iation is homozygous because each strain is highly
inbred. Environmental effects on expression are limited
because the rats are kept in a controlled facility. More-
over, by analyzing transcriptomes of multiple animals of
the same strain biological variation can be accounted
for. Therefore, we could directly investigate the effect of
genetic variation on quantitative and qualitative diversity
in transcription in vivo.
It has been reported before that a large part of the
variation in transcription levels can be assigned to
CNVs [24,25] and that the level of contribution is
related to the size of the CNV [26]. In contrast, recent
studies on different inbred mouse strains have suggested
a relatively small role for SVs on phenotypic and tran-
scriptional variation. However, the strongest QTLs were
enriched for effects of the variant type SV [27,28].
In line with these latter reports, we found that the
total amount of genes affected by SVs is lower than that
of the SNVs and indels (108 versus 489), but when SVs
are involved, the effects are more likely to be prominent.
We have estimated which type of variants are the best
predictors for differential expression by considering
which proportion of the expressed genes carrying a spe-
cific type of mutation are differentially expressed. Using
this criterion, duplications are the best predictors for
differential expression. Expanding the analyses to more
tissues and more rat strains can further generalize the
predictive value of different types of genomic variants.
Moreover, the predictive value of especially SNVs and
indels can be different in organisms for which the gene
annotation is more accurate - for example, in human. It
should be noted that our assessments are aimed towards
functional predictions based on whole genome analyses.
The strong predictive value of stop and splice mutations
as de novo events or as recessive alleles in congenital
disease, for example, is not questioned here. However,
our data do illustrate the importance of full spectrum
analyses of genomic variants in (clinical) genetic studies.
Moreover, the data of specific genes are illustrative for
the diversity of mechanisms by which SVs can change
expression. By nucleotide analyses of RNA-seq data in
gene amplifications we found examples that show gene
amplification and subsequent diversification do not
necessarily lead to pseudogenes, but can result in
expression from both the original and the duplicated
locus and can result in a novel transcript. Deletions of
>2 kb of repetitive elements located in introns were
found in genes with a change in level of transcription. It
has been described that remnants of repetitive elements
can form transcriptional start sites and binding sites for
transcription factors. As it is also shown that the repeti-
tive sequences are unstable sites in the genome and are
thus likely to mutate, these sequences could be a major
direct cause of transcriptional variation between indivi-
duals. Due to the limited size (3.0 to 6.4 kb) and the
repetitive nature of the encompassed sequence, this type
of deletion is largely missed in predictions based on
NGS read coverage. These findings thus illustrate the
importance of including mate-pair analyses in genetic
studies.
Combining stop codon-related small genomic variants
and the SVs, only 37 of the 532 differentially expressed
genes contain a genomic variant with a predicted effect
on gene expression. Equivalently, changes in transcript
structure rarely overlap with genomic variants. This sug-
gests that the major part of both qualitative and quanti-
tative variation in the transcriptome is regulated by
unknown regulatory elements or result from changes in
transcriptional networks. Segregation analyses of the
transcriptome in the RI panel can dissect these cis and
trans regulatory factors, both for gene expression levels
and splicing variation.
We have not evaluated the genetic content of the indi-
vidual 30 RI lines. Some de novo mutations may have
occurred in the 80 generations of breeding. Indeed, in a
previous study evaluating CNV patterns in the founder
lines and two of the RI lines, three novel CNVs were
detected in the RI strains compared to 626 normally
segregating CNVs [29]. Nevertheless, as lines are crossed
without mixing from the F2 generation on, all novel var-
iants will be private to a single line. Although such var-
iants could affect biology, they do not affect the
genotype-phenotype segregation pattern within the RI
panel, which is the common type of use for this genetic
system.
Materials and methods
Sequencing library preparation
Below we describe the detailed library preparation protocol.
All enzymatic reactions were performed according to man-
ufacturers’ conditions unless indicated otherwise. We per-
formed sample cleaning in between all enzymatic reactions.
To keep the description below concise we only describe the
cleanup once here: cleanup was performed using QIAquick
cleanup kit (Qiagen, Venlo, The Netherlands) according to
the manufacturer’s instructions. Elution was performed by
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two incubations with 35 µl of EB and incubating at 20°C for
2 minutes.
For preparation of BN-Lx DNA fragment libraries geno-
mic DNA from BN-Lx liver tissue was sheared using the
Covaris sonicator (6 minutes, 6X 16 mm AFA fiber Tube,
duty cycle 20%, intensity 5, cycles/burst 200 frequency
sweeping). End repair was performed (creating blunt 5’
phosphorylated ends) using the End-It kit (Epicentre,
Madison, Wisconsin, USA). Double-stranded P1 and P2
adapters (Applied Biosystems, Carlsbad, California, USA)
were ligated to 2 µg of sheared DNA using the Quick liga-
tion kit (New England Biolabs, Ipswich, Suffolk, UK). Nick
translation was performed on the ligation product using
10 U of DNA Polymerase I in Buffer 2 (New England
Biolabs) and incubating at 16°C for 30 minutes. DNA frag-
ments were size selected on 2.5% agarose gel, excising
125 to 175 bp fragments and using the MinElute Gel
extraction kit (Qiagen). Libraries were amplified using
Platinum Supermix (Invitrogen, Life Technologies Europe,
Bleiswijk, The Netherlands). The number of PCR cycles
used was determined in a trial titration PCR, such that the
amplification was still exponential in the last cycle. Ampli-
fication conditions were: 95°C for 5 minutes × cycles of
95°C for 15 s, 62°C for 15 s and 70°C for 1 minute, fol-
lowed by one cycle of 70°C for 5 minutes. , where ‘X’ is
the number of cycles that was determined by the trial
titration PCR.
The mate-pair library of BN-Lx was obtained by shear-
ing liver genomic DNA using the Hydroshear (Digilab
Holliston, Massachusetts, USA). Sheared DNA (50 µg)
was loaded on a 0.6% agarose gel and fragments of 5 to
7 kb were excised. Fragments were circularized incorpor-
ating an internal adapter (Applied Biosystems) using
Quick ligase (New England Biolabs), applying it on 4 µg
of DNA in a 900 ml reaction volume. Uncircularized
DNA was removed using plasmid safe DNase (Epicentre).
Nick translation was performed using 18 U of DNA Poly-
merase I (New Engalnd Biolabs) and incubating on ice
for 13 minutes. The DNA circles were cut using T7 exo-
nuclease (New Engaland Biolabs) and subsequently by S1
nuclease (New England Biolabs). End repair was per-
formed using the End-It kit (Epicentre). The library was
bound to 150 µl streptavidin coated dynal beads (Invitro-
gen) that were pre-washed with bovine serum albumin.
P1 and P2 adapters were ligated to the DNA using Quick
Ligase (New England Biolabs). The library was nick-
translated using DNA Polymerase I in Buffer 2 (New
England Biolabs) and amplified using Platinum Supermix
(Invitrogen). Amplification conditions were: 95°C for
5 minutes followed by 15 cycles of 95°C for 15 s, 62°C for
15 s and 70°C for 1 minute, followed by 70°C for 5 min-
utes. The library was size-selected on a 2.5% agarose gel,
excising the fragments between 225 and 250 bp in size
and using the MinElute Gel extraction kit (Qiagen).
The construction of the LMP library for the reference
BN was performed essentially the same as for BN-Lx
except that the DNA fragments were excised between 2
and 4 kb.
In the preparation of RNA-seq libraries cleanup in
between enzymatic reaction was performed by phenol-
chloroform (pH 4.5) extractions. RNA-seq libraries were
made starting with 50 µg total RNA from liver tissue
per animal and selecting the poly-adenylated fraction
using the micro polyA purist kit (Ambion Life Technol-
ogies Europe, Bleiswijk, The Netherlands). Capped
mRNA was selected using the eukaryotic mRNA only
kit (Epicenter). Fragmentation of the RNA was per-
formed by incubating in 20 µl 3mM MgCl, buffered in
10 mM Tris pH8 for 15 minutes at 95°C. SREK Adapter
A (Applied Biosystems) was ligated to the fragmented
sample in SREK hybridization solution (Applied Biosys-
tems) and incubated for 5 minutes at 65°C. After chil-
ling on ice, ligation was performed according to the
SREK protocol. The samples were size-selected, excising
110 to 200 nucleotide fragments from a 10% denaturing
polyacrylamide gel. Reverse transcription was performed
using 200 U RT enzyme (Promega Madison, Wisconsin,
USA) and incubating at 37°C for 30 minutes. PCR
amplification of the libraries was performed according
to the SREK protocol followed by excision of 150 to
200 bp fragments from a 6% native polyacrylamide gel.
Illumina genome sequencing libraries for SHR were
prepared using methods described previously [30].
Resulting libraries were sequenced on Illumina HiSeq-
2000 according to the manufacturer’s instructions.
Next generation sequencing
To generate genome sequencing data for BN-Lx, one 36
bp fragment, two 50 bp fragments and one paired-end
library were processed on AB/Solid version 2, AB/Solid
version 3 and AB/Solid version 4, respectively. The mate-
pair library of BN-Lx was sequenced on AB/Solid version
3 reading 40 bp from both the forward and the reverse
tag. RNA-seq libraries were sequence on AB/Solid version
3, generating 50 bp reads. For SHR, 100 bp paired-end
reads (2 × 100) were sequenced on Illumina HiSeq-2000
version 1.5 using libraries generated before [10] following
the manufacturer’s instructions.
The reference BN data used to filter our SNV and
indel data set were produced on AB/Solid.
SNV and indel calling
SNV and indels were called with two algorithms.
SNV and indel caller 1
All sequencing reads were mapped with Burrows-Wheeler
Aligner (BWA-0.5.8c) (settings: -c -l 25 -k 2 -n 10) [31] to
the BN/NHsdMcwi reference genome RGSC-3.4 [32].
SNVs and indels were called using an adapted version of
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Samtools pileup and custom perl scripts (available on
request). Filtering of the SNVs and indels was done as fol-
lows: reads that map to multiple positions in the genome
and reads that were likely to result from clonal expansion
in one of the PCR steps in the sequencing protocol (reads
with identical read start position and strand) were dis-
carded. Alleles should be detected by at least three sequen-
cing reads with a high mapping quality (>30) of the variant
base. SNV positions where an indel was detected within
10 bp were discarded because indels give mapping artifacts
that lead to false positive SNVs. The remaining potential
variant positions were separated based on the percentage
of the calls that are non-reference (pnr). Positions with a
pnr smaller than 10 were called reference, between 25 and
75 were considered potential heterozygous, and above
75 were called homozygous SNVs. The potential heterozy-
gous positions were filtered to have no more than three
times the median coverage to avoid repeat related errors.
Indels were called with a pnr of 40 and higher. This was
done because indel positions are harder to map and are
covered by more misaligned reads, which causes a drop in
the percentage of reads that predict the indel.
Many false SNVs and indels will be systematic and
detected in more than one rat strain. These false SNVs
will include errors in the reference genome but also sys-
tematic noise, such as sequencing errors and mapping
artifacts. We therefore used the three genome data sets
to filter each other and selected SNV and indel positions
found in only one strain that were called reference in
the other two strains.
SNV and indel caller 2
Quality filtered Illumina paired-end as well as mate-pair
reads for SHR were mapped to the BN/NHsdMcwi
reference genome RGSC-3.4 [32] using the read align-
ment software Burrows-Wheeler Aligner (BWA-0.5.8c)
[31] with all default parameters except for the read trim-
ming parameter. Reads were trimmed if base quality
value decreased to <20 at the base where read quality
decreased to <20. SOLiD reads for the BN-Lx genome
were mapped to the BN/NHsdMcwi reference genome
using software BFAST [33] using default parameters and
ten indexes.
Genomic variants (SNPs and short indels) were detected
using the Genome Analysis Toolkit (GATK version
1.0.6001) [34,35]. Instead of calling variants independently
in each strain/genome, variants were called in both the
genomes simultaneously using the multisample variant
calling functionality of GATK. This allows identification of
genomic variants between two strains irrespective of the
reference genome. Before calling variants, data were pro-
cessed using various pre-processing steps including
i) removal of clonal reads, ii) indel realignment, and iii)
base quality recalibration. GATK variant quality score
recalibration was used to filter out potential false positives.
Based on SNP quality score, the top 30% SNPs were used
as a training set to build the Gaussian mixture model. We
used a cutoff such that 99% of the SNPs in the training set
were included in the final SNP set.
SNV and indel overlap
The results of both SNV and indel callers were com-
pared and SNVs and indels called uniquely in BN-Lx or
SHR in both sets were used for downstream analyses
described in the paper.
CNVs and SVs
Sequence read coverage of BN-Lx and SHR were both
compared to the BN reference using DWAC-seq (VG,
unpublished data). This software tool employs a binary
segmentation algorithm, using a dynamic window to
compare coverage between two samples. A window size
of 250 bp was applied. The analyses were done with
both ambiguity 1 and ambiguity 10 (ambiguity = maxi-
mum number of hits per sequencing read that is
allowed to include the read in the analyses) for BN-Lx
and SHR. For each set deletions were detected with
threshold of ratio sample/BN <0.4. For calling amplifica-
tions, ratio sample/BN>1.6 was required. The overlap
between the sets called with ambiguity 1 and 10 was
selected. CNVs that were detected in both strains were
removed from the list.
Analyzing the mate-pair data, we scored deletions and
tandem duplications found only in SHR and not in BN.
We required at least three independent pairs to predict
the variant. For inversions we required both breakpoints
to be covered by at least one pair. For duplications we
required the size to be larger than 3,100 bp. For dele-
tions we analyzed the distribution of the distance
between the mapping positions of pairs. We set the
threshold at 1% of this distribution and required at least
three of these pairs to overlap each other to call a dele-
tion. In addition, the median insert size of all pairs
spanning potential deletions was taken into account.
Threshold was set at (median(SHR) - median(BN))/med-
ian(SHR) > 0.25.
Differential expression
RNA sequencing NGS data were mapped using BWA
(settings: -c -l 25 -k 2 -n 10). As a measure, the total
number of reads mapping to the total coding sequence
of a gene was used (gene annotation ensemble 56). Read
numbers were normalized to the total number of reads
mapping within coding sequences. A gene was called
expressed if the average normalized read counts were
>10 in at least one of the strains (SHR or BN-Lx). t-Test
statistics were calculated for each gene. Genes were
called differentially expressed if the difference was more
than two-fold different with P-value <0.05. To correct
for multiple testing effects, we swapped samples of
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strains and calculated P-values and fold change for each
swap combination possible. In this total set we found,
on average, 23 genes with P < 0.05 and a two-fold
change. Of the 532 differentially expressed genes, 23 can
be expected to be false. This resulted in a FDR of
23/532, thus an FDR <5%.
To verify mRNA level differences, qPCR was per-
formed using BioRad’s MyIQ™ iCycler (Veenendaal,
The Netherlands). cDNA was generated from 1 μg of
isolated mRNA using Ambion’s RETROscript® Kit
(#AM1710). All reactions were done in triplicates in a
96-well optical-well plate format. For each reaction
10 μl 2x iQ SYBR Green Supermix (BioRad #170-8880),
2 μl cDNA (1 ng/μl), 1.2 μl forward and reverse primer
(0.8 μM final concentration) and 6.8 μl H20 were used.
Reaction conditions were as follows: 3 minutes at 95°C
followed by 40 cycles of 30 s at 95°C and 30 s at 59°C.
Visualization of RNA-seq data was done in TagBrowser,
available on request.
Splicing
To detect changes in splicing we created a database of
all exon sequence combinations (ensemble 56) of
exons within 1 Mb of each other (gene annotation
ensemble 56). RNA-seq reads were mapped to this
database with BWA (settings: -c -l 25 -k 2 -n 10).
Mapped reads were filtered to only map to one loca-
tion and have less than five mismatches. The number
of remaining reads were normalized to the total num-
ber of reads mapping to the genes and exons with
mapping bias due to SNVs in the start or end of the
exon being excluded. We then detected for junctions
that were found more frequently in one of the two
strains such that abs(A) >4 (at least 4 reads were in
one of the strains), where A = log2(BN-Lx) - log2
(SHR).
Linking genomic and transcriptomic variants
Functional prediction of SNVs and indels was performed
using Variant effect predictor 2.0 [36]. To determine the
overlap between SVs and genes, we selected known pro-
tein coding genes with a RefSeq ID. Conservations
scores (phastCons9way) used were obtained from the
UCSC Table Browser [37].
Data availability
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